| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1035: Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease |
|
Medicine details |
|
| Medicine name | vadadustat (Vafseo®) |
| Formulation | 150 mg, 300 mg and 450 mg film-coated tablet |
| Reference number | 3014 |
| Indication | Treatment of symptomatic anaemia associated with chronic kidney disease (CKD) in adults on chronic maintenance dialysis |
| Company | MEDICE Arzneimittel Pütter GmbH & Co. KG |
| BNF chapter | Nutrition & blood |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 13/05/2024 |
| NICE guidance | |